GW117: A novel serotonin (5-HT2C) receptor antagonist and melatonin (MT1/MT2) receptor agonist with potential antidepressant-like activity in rodents

被引：11

作者：

Gao, Nana ^{[1
]}

Zheng, Wei ^{[2
]}

Murezati, Tiliwaerde ^{[2
]}

Gu, Wei ^{[3
]}

Li, Xiaorong ^{[2
]}

Jin, Zengliang ^{[2
]}

机构：

[1] Captial Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg & Clin Nutr, Beijing, Peoples R China

[2] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100069, Peoples R China

[3] Beijing Guangwei Pharmaceut Technol Co Ltd, Beijing, Peoples R China

来源：

CNS NEUROSCIENCE & THERAPEUTICS | 2021年 / 27卷 / 06期

基金：

中国国家自然科学基金;

关键词：

5‐ HT2C receptor; antidepressant; GW117; melatonin receptor; REUPTAKE INHIBITORS; AGOMELATINE; NOREPINEPHRINE; DRUGS; MODEL; DEPRESSION; STRESS; RATS;

D O I：

10.1111/cns.13630

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Aims To evaluate the antidepressant-like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests. Methods We investigated the target profile of GW117 using [S-35]-GTP gamma S and [H-3]PIP binding. Using the forced swimming test and chronic unpredictable stress in rats, tail suspension test in mice and rats, and learned helplessness model in mice, we further revealed the antidepressant-like and anxiolytic-like effects of GW117. Results The current study suggests that GW117 displays serotonin 2C (5-HT2C) receptor antagonist and melatonin type 1 and 2 (MT1/MT2) receptor agonist properties, as well as evident antidepressant and anxiolytic effects. Conclusion These data suggest that GW117 is probably a potent antidepressant.

引用

页码：702 / 713

页数：12

共 50 条

[21] Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT2C receptor agonist but not by a 5-HT2A receptor antagonist [J].

Guy, Elizabeth Glenn ;

Fletcher, Paul J. .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 125 :40-47

[22] S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models [J].

Anne Dekeyne ;

Clotilde Mannoury la Cour ;

Alain Gobert ;

Mauricette Brocco ;

Françoise Lejeune ;

Florence Serres ;

Trevor Sharp ;

Annie Daszuta ;

Amélie Soumier ;

Mariusz Papp ;

Jean-Michel Rivet ;

Gunnar Flik ;

Thomas I. Cremers ;

Olivier Muller ;

Gilbert Lavielle ;

Mark J. Millan .

Psychopharmacology, 2008, 199 :549-568

[23] S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models [J].

Dekeyne, Anne ;

la Cour, Clotilde Mannoury ;

Gobert, Alain ;

Brocco, Mauricette ;

Lejeune, Francoise ;

Serres, Florence ;

Sharp, Trevor ;

Daszuta, Annie ;

Soumier, Amelie ;

Papp, Mariusz ;

Rivet, Jean-Michel ;

Flik, Gunnar ;

Cremers, Thomas I. ;

Muller, Olivier ;

Lavielle, Gilbert ;

Millan, Mark J. .

PSYCHOPHARMACOLOGY, 2008, 199 (04) :549-568

[24] Luzindole Hippocampal Neurogenesis and Modulates Depressive-Like Behaviors via Distinct Actions at the MT1 and MT2 Melatonin Receptors in C3H/HeN Mice [J].

Dubocovich, Margarita L. ;

Liu, Jiabei .

NEUROPSYCHOPHARMACOLOGY, 2015, 40 :S342-S343

[25] Chemistry, Analysis, Pharmacokinetics and Pharmacodynamics Aspects of Lorcaserin, a Selective Serotonin 5-HT2C Receptor Agonist: An Update [J].

Sharma, Sanjay ;

Aware, Komal S. ;

Hatware, Ketan ;

Patil, Kiran .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (09) :768-778

[26] Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties [J].

Canale, Vittorio ;

Kotanska, Magdalena ;

Dziubina, Anna ;

Stefaniak, Matylda ;

Siwek, Agata ;

Starowicz, Gabriela ;

Marciniec, Krzysztof ;

Kasza, Patryk ;

Satala, Grzegorz ;

Duszynska, Beata ;

Bantreil, Xavier ;

Lamaty, Frederic ;

Bednarski, Marek ;

Sapa, Jacek ;

Zajdel, Pawel .

MOLECULES, 2021, 26 (13)

[27] 5HT(2C) receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats [J].

Moreau, JL ;

Bos, M ;

Jenck, F ;

Martin, JR ;

Mortas, P ;

Wichmann, J .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (03) :169-175

[28] Effects of (-)-MBP, a novel 5-HT2C agonist and 5-HT2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice [J].

Sathe, Preeti K. ;

Ramdasi, Gargi R. ;

Giammatteo, Kaylie ;

Beauzile, Harvens ;

Wang, Shuyue ;

Zhang, Heng ;

Kulkarni, Praveen ;

Booth, Raymond G. ;

Ferris, Craig F. .

PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (05)

[29] Antidepressant-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents [J].

Yamada, Koji ;

Kobayashi, Minoru ;

Mori, Akihisa ;

Jenner, Peter ;

Kanda, Tomoyuki .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 114 :23-30

[30] The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents [J].

Jensen, Anders A. ;

Cecchi, Claudia R. ;

Hibicke, Meghan ;

Bach, Astrid H. ;

Kaadt, Erik ;

Marcher-Rorsted, Emil ;

Nichols, Charles D. ;

Elfving, Betina ;

Kristensen, Jesper L. .

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025, 8 (06) :1791-1803

← 1 2 3 4 5 →